MoneySTAT News
STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.
Join the argument
House rules →Comments load as you scroll.